Početna › B-stanična leukemija
Kliničke studije za B-stanična leukemija koje traže sudionike u SAD-u
17 studija za B-stanična leukemija traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX7 studija
- Washington, DC5 studija
- Dallas, TX5 studija
- Columbus, OH4 studija
- Portland, OR4 studija
- Philadelphia, PA3 studija
- Spokane, WA3 studija
- Boston, MA3 studija
- New York City, NY3 studija
- San Diego, CA3 studija
- Clifton, NJ3 studija
- Charlotte, NC3 studija
- Louisville, KY3 studija
- Pittsburgh, PA3 studija
- Edison, NJ3 studija
- Denver, CO3 studija
- Chicago, IL3 studija
Po državama
- Colorado3 studija
- Florida3 studija
- Illinois4 studija
- Kalifornija7 studija
- Kansas3 studija
- Kentucky3 studija
- Maryland5 studija
- Massachusetts3 studija
- Minnesota3 studija
- New Jersey4 studija
- New York4 studija
- North Carolina5 studija
- Ohio7 studija
- Oregon4 studija
- Pennsylvania5 studija
- Texas12 studija
- Washington5 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06542250CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
U tijeku regrutacijaFaza 1/2
Od 3 do 39 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05442515Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT00923507Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
U tijeku regrutacijaFaza 4
Od 18 do 130 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06651970Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT04728893Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
U tijeku regrutacijaFaza 1
Do 75 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT06345027A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06564038Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
U tijeku regrutacijaFaza 3
Od 18 do 18 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07509151Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
U tijeku regrutacijaFaza 1
12 Months – 25 Years · Oba spola · Ažurirano 4. ruj 2026. · NCT05010564Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
U tijeku regrutacijaFaza 2
Od 7 do 25 godina · Oba spola · Ažurirano 19. kol 2026. · NCT05082519A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05254743ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT07342478A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 31. srp 2026. · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
U tijeku regrutacijaFaza 1/2
Od 12 do 95 godina · Oba spola · Ažurirano 15. tra 2026. · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
U tijeku regrutacijaFaza 2
Od 18 do 66 godina · Oba spola · Ažurirano 17. ožu 2026. · NCT06859424A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
U tijeku regrutacijaOpažajna studija
Od 1 do 23 godina · Oba spola · Ažurirano 25. velj 2026. · NCT07422337Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 22. sij 2026. · NCT06357754Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.